A South African study of the Oxford-AstraZeneca vaccine trial has indicated that the vaccine does not have the required 60% efficacy against the variant of the coronavirus found in South Africa. The study was published in the New England Journal of Medicine. This is the first study to raise the[…]
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.